Prevalence of abnormal amniotic fluid index and its association with maternal and perinatal outcomes: a retrospective observational study
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20260540Keywords:
Amniotic fluid index, Oligohydramnios, Polyhydramnios, Perinatal outcome, Maternal outcomeAbstract
Background: Abnormal amniotic fluid volume is an established indicator of fetal wellbeing and has been linked to increased maternal and perinatal morbidity. Ultrasonographic assessment using the amniotic fluid index (AFI) enables early identification of high-risk pregnancies and guides obstetric decision making. Objectives of the study was to determine the prevalence of abnormal amniotic fluid volume and evaluate its association with adverse maternal and perinatal outcomes.
Methods: This retrospective observational study was conducted at a tertiary care teaching hospital and included 300 consecutive singleton pregnancies beyond 28 weeks’ gestation with documented AFI measurements. Amniotic fluid volume was categorized as oligohydramnios (AFI ≤5 cm), normal AFI (5.1–23.9 cm), and polyhydramnios (AFI ≥24 cm). Maternal outcomes assessed included induction of labour, mode of delivery, postpartum hemorrhage, and maternal intensive care unit (ICU) admission. The primary perinatal outcome was a composite of meconium-stained liquor, neonatal intensive care unit (NICU) admission, low Apgar score at 5 minutes (<7), and low birth weight (<2500 g). Statistical analysis included chi square tests and multivariable logistic regression.
Results: Of the 300 pregnancies, 240 (80%) had normal AFI, 45 (15%) had oligohydramnios, and 15 (5%) had polyhydramnios. Cesarean delivery was significantly more frequent in pregnancies with abnormal AFI (53.3% in oligohydramnios and 46.7% in polyhydramnios) compared to normal AFI (29.2%; p=0.001). Abnormal AFI was associated with significantly higher rates of meconium-stained liquor, NICU admission, low Apgar score, and low birth weight (all p<0.001). On multivariable analysis, abnormal AFI remained independently associated with adverse perinatal outcomes.
Conclusions: Abnormal amniotic fluid volume, particularly oligohydramnios, is associated with increased obstetric intervention and adverse perinatal outcomes. AFI is a simple, non-invasive, and effective tool for identifying high risk pregnancies and optimizing maternal and neonatal care.
References
Brace RA. Physiology of amniotic fluid volume regulation. Clin Obstet Gynecol. 1997;40(2):280-9. DOI: https://doi.org/10.1097/00003081-199706000-00005
Phelan JP, Smith CV, Broussard P, Small M. Amniotic fluid volume assessment with the four-quadrant technique at 36–42 weeks’ gestation. J Reprod Med. 1987;32(7):540-2.
Moore TR, Cayle JE. The amniotic fluid index in normal human pregnancy. Am J Obstet Gynecol. 1990;162(5):1168-73. DOI: https://doi.org/10.1016/0002-9378(90)90009-V
Casey BM, McIntire DD, Bloom SL, Lucas MJ, Santos R, Twickler DM. Pregnancy outcomes after antepartum diagnosis of oligohydramnios at or beyond 34 weeks’ gestation. Am J Obstet Gynecol. 2000;182(4):909-12. DOI: https://doi.org/10.1016/S0002-9378(00)70345-0
Locatelli A, Vergani P, Toso L, Verderio M, Pezzullo JC, Ghidini A. Perinatal outcome associated with oligohydramnios in uncomplicated term pregnancies. Arch Gynecol Obstet. 2004;269(2):130-3.. DOI: https://doi.org/10.1007/s00404-003-0525-6
Biggio JR, Wenstrom KD, Dubard MB, Cliver SP. Hydramnios prediction of adverse perinatal outcome. Obstet Gynecol. 1999;94(5):773-7. DOI: https://doi.org/10.1016/S0029-7844(99)00370-1
Chandra P, Kaur SP, Hans DK, Kapila AK. The impact of amniotic fluid volume assessed intrapartum on perinatal outcome. Obstet Gynecol India. 2000;50:49-52.
Rutherford SE, Phelan JP, Smith CV, Jacobs N. The four-quadrant assessment of amniotic fluid volume: An adjunct to antepartum fetal heart rate testing. Obstet Gynecol. 1987;70(3):353-6.
Manning FA, Hill LM, Platt LD. Qualitative amniotic fluid volume determination by ultrasound: Antepartum detection of intrauterine growth retardation. Am J Obstet Gynecol. 1981;139(3):254-8. DOI: https://doi.org/10.1016/0002-9378(81)90004-1
Chauhan SP, Sanderson M, Hendrix NW, Magann EF, Devoe LD. Perinatal outcome and amniotic fluid index in the antepartum and intrapartum periods: A meta-analysis. Am J Obstet Gynecol. 1999;181(6):1473-8. DOI: https://doi.org/10.1016/S0002-9378(99)70393-5
Magann EF, Chauhan SP, Doherty DA, Barrilleaux PS, Martin JN Jr, Morrison JC. Predictability of intrapartum and neonatal outcomes with the amniotic fluid volume distribution: a reassessment using the amniotic fluid index, single deepest pocket, and a dye-determined amniotic fluid volume. Am J Obstet Gynecol. 2003;188(6):1523-7. DOI: https://doi.org/10.1067/mob.2003.381
Nabhan AF, Abdelmoula YA. Amniotic fluid index versus single deepest vertical pocket as a screening test for preventing adverse pregnancy outcome. Cochrane Database Syst Rev. 2008;(3):CD006593. DOI: https://doi.org/10.1002/14651858.CD006593